Skip to main content Accessibility help
  • Print publication year: 2014
  • Online publication date: April 2014

Chapter 26 - Respiratory complications of movement disorders

from Section V - Systemic complications of movement disorders



Movement disorders can be divided into hypokinetic disorders, manifested by paucity or slowness (bradykinesia) of movement, hyperkinetic disorders, dominated by excessive, abnormal involuntary movements, hypertonic disorders, such as spasticity and stiff person syndrome, and ataxia dominated by incoordination of movement (see Table 26.1). While in most patients the movement disorder is dominated by either parkinsonism, usually caused by Parkinson’s disease (PD), or some involuntary movement such as tremor, dystonia, chorea, tics, myoclonus, or stereotypy (Jankovic 2009a), non-motor, autonomic, or systemic features may accompany the primary motor disorder. In this chapter we will focus on respiratory problems encountered by patients with movement disorders and provide a guide to the clinical diagnosis, classification, and treatment.

Hypokinetic movement disorders

Hypokinetic movement disorders are divided into classical PD and atypical parkinsonism (also referred to as parkinsonism plus syndromes). Compared to PD patients, patientswith atypical parkinsonism usually lack the typical rest tremor, and tend to have a poor response to levodopa and a more rapid progression, as well as additional (“plus”) features, such as ophthalmoparesis in progressive supranuclear palsy (PSP) and dysautonomia in multiple system atrophy (MSA) (Fahn et al. 2011).

Related content

Powered by UNSILO
Abdo, W. F., van de Warrenburg, B. P., Burn, D. J., Quinn, N. P., and Bloem, B. R. (2010). “The clinical approach to movement disorders,” Nat. Rev. Neurol. 6: 29–37.
Adam, O. R., Ferrara, J. M., and Jankovic, J. (2009). “Motor-phonic tic mimicking essential palatal myoclonus,” Mov. Disord. 24: 2030–2.
Altman, K. W., Simpson, C. B., Amin, M. R., Abaza, M., Balkissoon, R., and Casiano, R. R. (2002). “Cough and paradoxical vocal fold motion,” Otolaryngol. Head Neck Surg. 127: 501–11.
Andersohn, F. and Garbe, E. (2009). “Cardiac and non-cardiac fibrotic reactions caused by ergot-and non-ergot-derived dopamine agonists,” Mov. Disord. 24: 129–33.
Antonini, A. and Poewe, W. (2007). “Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson’s disease,” Lancet Neurol. 6: 826–9.
Apps, M. C., Sheaff, P. C., Ingram, D. A., Kennard, C., and Empey, D. W. (1985). “Respiration and sleep in Parkinson’s disease,” J. Neurol. Neurosurg. Psychiatry 48: 1240–45.
Asahina, M., Yamaguchi, M., Fukutake, T., and Hattori, T. (2000). “Sleep apnea in multiple system atrophy,” Nippon Rinsho 58(8): 1722–7.
Ashour, R. and Jankovic, J. (2006). “Joint and skeletal deformities in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy,” Mov. Disord. 21: 1856–63.
Azher, S. N. and Jankovic, J. (2005). “Camptocormia: pathogenesis, classification, and response to therapy,” Neurology 65: 355–9.
Bannister, R., Gibson, W., Michaels, L., and Oppenheimer, D. R. (1981). “Laryngeal abductor paralysis in multiple system atrophy,” Brain 104: 351–68.
Banno, K., Hobson, D. E., and Kryger, M. H. (2005). “Long-term treatment of sleep breathing disorder in a patient with Huntington’s disease,” Parkinsonism Relat. Disord. 11: 261–4.
Barton, B., Zauber, E., and Goetz, C. (2009). “Movement disorders caused by medical disease,” Semin. Neurol. 29: 97–110.
Belafsky, P. C. and Postma, G. N. (2004). “Vocal fold augmentation with calcium hydroxylapatite,” Otolaryngol. Head Neck Surg. 131: 351–4.
Benarroch, E. E., Schmeichel, A. M., Low, P. A., and Parisi, J. E. (2007). “Depletion of putative chemosensitive respiratory neurons in the ventral medullary surface in multiple system atrophy,” Brain 130(Pt. 2): 469–75.
Bhimani, M. (2011). “Respiratory dyskinesia – an under-recognized side-effect of neuroleptic medications,” J. Pak. Med. Assoc. 61: 930–2.
Blitzer, A. and Brin, M. F. (1991). “Laryngeal dystonia: a series with botulinum toxin therapy,” Ann. Otol. Rhinol. Laryngol. 100: 85–9.
Blitzer, A. and Brin, M. F. (2007). “Laryngeal dystonia: a series with botulinum toxin therapy,” Mov. Disord. 22: 673–8.
Blitzer, A., Brin, M. F., Fahn, S., and Lovelace, R. E. (1988). “Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases,” Laryngoscope 98: 636–40.
Boesch, S. M., Frauscher, B., Brandauer, E., Wenning, G. K., Poewe, W., and Högl, B. (2006). “Restless legs syndrome and motor activity during sleep in spinocerebellar ataxia type 6,” Sleep Med. 7: 529–32.
Bollen, E. L., Den Heijer, J. C., Ponsioen, C., Kramer, C., Van der Velde, E. A., Van Dijk, J. G., et al. (1988). “Respiration during sleep in Huntington’s chorea,” J. Neurol. Sci. 84: 63–8.
Bonelli, R. M. and Wenning, G. K. (2006). “Pharmacological management of Huntington’s disease: an evidence-based review,” Curr. Pharm. Des. 12: 2701–20.
Braun, N., Abd, A., Baer, J., Blitzer, A., Stewart, C., and Brin, M. (1995). “Dyspnea in dystonia. A functional evaluation,” Chest 107: 1309–16.
Breakfield, X. O., Blood, A., Li, Y., Hallett, M., Hanson, P. I., and Standaert, D. G. (2008). “The pathophysiological basis of dystonias,” Nat. Rev. Neuroscience 9: 222–34.
Brown, L. K. (1994). “Respiratory dysfunction in Parkinson’s disease,” Clin. Chest Med. 15: 715–27.
Byard, R. W., Wick, R., and Gilbert, J. D. (2008). “Conditions and circumstances predisposing to death from positional asphyxia in adults,” J. Forensic Leg Med. 15: 415–19.
Carotenuto, M., Esposito, M., D’Aniello, A., Rippa, C. D., Precenzano, F., Pascotto, A., et al. (2012). “Polysomnographic findings in Rett syndrome: a case-control study,” Sleep Breath. [E-pub ahead of print].
Carroll, J. L. and Agarwal, A. (2010). “Development of ventilatory control in infants,” Paediatr. Respir. Rev. 11: 199–207.
Chaudhuri, K. R. and Schapira, A. H. (2009). “Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment,” Lancet Neurol. 8: 464–74.
Chiu, H. F., Lee, S., and Chan, C. H. (1991). “Misdiagnosis of respiratory dyskinesia,” Acta Psychiatr. Scand. 83: 494–5.
Chiu, H. F., Lam, L. C., Chan, C. H., Ho, C. K., and Shum, P. P. (1993). “Clinical and polygraphic characteristics of patients with respiratory dyskinesia,” Br. J. Psychiatry 162: 828–30.
Cho, J. W., Chu, K., and Jeon, B. S. (2001). “Case of essential palatal tremor: atypical features and remarkable benefit from botulinum toxin injection,” Mov. Disord. 16: 779–82.
Chou, K. L., Evatt, M., Hinson, V., and Kompoliti, K. (2007). “Sialorrhea in Parkinson’s disease: a review,” Mov. Disord. 22: 2306–13.
Christodoulou, C. and Kalaitzi, C. (2005). “Antipsychotic drug-induced acute laryngeal dystonia: two case reports and a mini review,” J. Psychopharmacol. 19: 307–11.
Cisneros, E. and Braun, C. M. (1995). “Vocal and respiratory diadochokinesia in Friedreich’s ataxia. Neuropathological correlations,” Rev. Neurol. 151: 113–23.
Cohen, J. J. and Madias, N. E. (1985). “Respiratory alkalosis and acidosis” in Seldin, D. W. and Giebisch, C. (eds.), The Kidney: Physiology and Pathophysiology (New York: Raven Press).
Cvietusa, P. J., Nimmagadda, S. R., Wood, R., and Liu, A. H. (1995). “Diaphragmatic flutter presenting as inspiratory stridor,” Chest 107: 872–5.
de Mello, R. A., Ferreira, D., Dias da Costa, J. M., Rosas, M. J., and Quinaz, J. M. (2010). “Multiple-system atrophy with cerebellar predominance presenting as respiratory insufficiency and vocal cords paralysis,” Case Report Med. [E-pub. ahead of print].
Deliberador, T. M., Marengo, G., Scaratti, R., Giovanini, A. F., Zielak, J. C., and Baratto Filho, F. (2011). “Accidental aspiration in a patient with Parkinson’s disease during implant-supported prosthesis construction: a case report,” Spec. Care Dentist. 31: 156–61.
Dhand, A., Birdi, S., and Rajput, A. H. (1998). “Frequency of respiratory disorders and bradycardia in essential tremor – consideration of treatment,” Parkinsonism Relat. Disord. 4: 7–10.
Dion, Y., Annable, L., Sandor, P., and Chouinard, G. (2002). “Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial,” J. Clin. Psychopharmacol. 22: 31–9.
Dobell, C. (1932). Antony van Leeuwenhoek and His “Little Animals,” Being Some Account of the Father of Protozoology and Bacteriology and his Multifarious Discoveries in these Disciplines Collected, Translated and Edited, from his Printed Works, Unpublished Manuscripts, and Contemporary Records (London: John Bale, Sons and Danielsson).
Easdown, L. J., Tessler, M. J., and Minuk, J. (1995). “Upper airway involvement in Parkinson’s disease resulting in postoperative respiratory failure,” Can. J. Anaesth. 42: 344–7.
Ebihara, S., Saito, H., Kanda, A., Nakajoh, M., Takahashi, H., Arai, H., et al. (2003). “Impaired efficacy of cough in patients with Parkinson disease,” Chest 124: 1009–15.
Ellen, R. L., Marshall, S. C., Palayew, M., Molnar, F. J., Wilson, K. G., and Man-Son-Hing, M. (2006). “Systematic review of motor vehicle crash risk in persons with sleep apnea,” J. Clin. Sleep Med. 2: 193–200.
Espay, A. J., Fox, S. H., Marras, C., Lang, A. E., and Chen, R. (2007). “Isolated diaphragmatic tremor: is there a spectrum in ‘respiratory myoclonus’?Neurology 69: 689–92.
Estenne, M., Hubert, M., and De Troyer, A. (1984). “Respiratory-muscle involvement in Parkinson’s disease,” N. Engl. J. Med. 311: 1516–17.
Fagbami, O. Y. and Donato, A. A. (2011). “Stridor and dysphagia associated with subthalamic nucleus stimulation in Parkinson disease,” J. Neurosurg. 115: 1005–6.
Fahn, S., Jankovic, J., and Hallett, M. (2011). Principles and Practice of Movement Disorders (Philadelphia, PA: Churchill Livingstone/Elsevier).
Fasano, A., Cadeddu, F., Guidubaldi, A., Piano, C., Soleti, F., Zinzi, P., et al. (2008). “The long-term effect of tetrabenazine in the management of Huntington disease,” Clin. Neuropharmacol. 31: 313–18.
Fekete, R. and Jankovic, J. (2012). “Childhood stiff-person syndrome improved with rituximab,” Case Rep. Neurol. 4: 92–6.
Fève, A., Angelard, B., and Lacau St. Guily, J. (1995). “Laryngeal tardive dyskinesia,” J. Neurol. 242: 455–9.
Fève, A., Angelard, B., Fenelon, G., Logak, M., Guillard, A., and Lacau St. Guily, J. (1993). “Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin,” Mov. Disord. 8: 217–19.
Fox, C. M., Ramig, L. O., Ciucci, M. R., Sapir, S., McFarland, D. H., Farley, B. G. (2006). “The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders,” Semin. Speech Lang. 27: 283–99.
Frank, S. and Jankovic, J. (2010). “Advances in the pharmacological management of Huntington’s disease,” Drugs 70: 561–71.
Fraser, R. S., Müller, N. L., Colman, N., and Paré, P. D. (1999). Diagnosis of Disease of the Chest, 4th edn., The Control of Breathing (Philadelphia, PA: WB Saunders), pp. 235–45.
Friedman, J. H., McCool, F. D., and Sherman, C. B. (2011). “Shortness of breath in Parkinson’s disease,” Parkinsonism Relat. Disord. 17: 495.
Gaig, C. and Iranzo, A. (2012). “Sleep-disordered breathing in neurodegenerative diseases,” Curr. Neurol. Neurosci. Rep. 12: 205–17.
Gallivan, G. J., Hoffman, L., and Gallivan, K. H. (1996). “Episodic paroxysmal laryngospasm: voice and pulmonary function assessment and management,” J. Voice 10: 93–105.
Galvez-Jimenez, N. and Lang, A. E. (1996). “Perioperative problems in Parkinson’s disease and their management: apomorphine with rectal domperidone,” Can. J. Neurol. Sci. 23: 198–203.
Gan, E. C., Lau, D. P., and Cheah, K. L. (2011). “Stridor in Parkinson’s disease: a case of ‘dry drowning’?J. Laryngol. Otol. 124: 668–73.
Gdynia, H. J., Sperfeld, A. D., Unrath, A., Ludolph, A. C., Sabolek, M., Storch, A., et al. (2009). “Histopathological analysis of skeletal muscle in patients with Parkinson’s disease and ‘dropped head’/’bent spine’ syndrome,” Parkinsonism Relat. Disord. 15: 633–9.
Ghorayeb, I., Bioulac, B., and Tison, F. (2005a). “Sleep disorders in multiple system atrophy,” J. Neural Transm. 112: 1669–75.
Ghorayeb, I., Yekhlef, F., Bioulac, B., and Tison, F. (2005b). “Continuous positive airway pressure for sleep-related breathing disorders in multiple system atrophy: long-term acceptance,” Sleep Med. 6: 359–62.
Ghorayeb, I., Yekhlef, F., Chrysostome, V., Balestre, E., Bioulac, B., and Tison, F. (2002). “Sleep disorders and their determinants in multiple system atrophy,” J. Neurol. Neurosurg. Psychiatry 72: 798–800.
Gilman, S., Chervin, R. D., Koeppe, R. A., Consens, F. B., Little, R., An, H., et al. (2003). “Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA,” Neurology 6: 35–9.
Grill, S. (2004). “Smothering dystonia in a patient with oromandibular dystonia,” Mov. Disord. 19: 1374–5.
Grillone, G. A., Blitzer, A., Brin, M. F., Annino, D. J., and Saint-Hilaire, M.-H. (1994). “Treatment of adductor laryngeal breathing dystonia with botulinum toxin type A,” Laryngoscope 104: 30–2.
Gross, R. D., Atwood, C. W., Ross, S. B., Eichhorn, K. A., Olszewski, J. W., and Doyle, P. J. (2008). “The coordination of breathing and swallowing in Parkinson’s disease,” Dysphagia 23: 136–45.
Hamakawa, S., Koda, C., Umeno, H., Yoshida, Y., Nakashima, T., Asaoka, K., et al. (2004). “Oropharyngeal dysphagia in a case of Huntington’s disease,” Auris Nasus Larynx 31: 171–6.
Hammer, M. J., Barlow, S. M., Lyons, K. E., and Pahwa, R. (2011). “Subthalamic nucleus deep brain stimulation changes velopharyngeal control in Parkinson’s disease,” J. Commun. Disord. 44: 37–48.
Hamzei, F., Rijntjes, M., Gbadamosi, J., Fuchs, K., Weiller, C., and Münchau, A. (2003). “Life-threatening respiratory failure due to cranial dystonia after dental procedure in a patient with multiple system atrophy,” Mov. Disord. 18: 959–61.
Harada, T., Mitsuoka, K., Kumagai, R., Murata, Y., Kaseda, Y., Kamei, H., et al. (2003). “Clinical features of malignant syndrome in Parkinson’s disease and related neurological disorders,” Parkinsonism Relat. Disord. 9(Suppl. 1): 15–23.
Hartman, D. E. (1988). “Stridor during dystonia phases of Parkinson’s disease,” J. Neurol. Neurosurg. Psychiatry 51: 161.
Hayashi, M., Isozaki, E., Oda, M., Tanabe, H., and Kimura, J. (1997). “Loss of large myelinated nerve fibres of the recurrent laryngeal nerve in patients with multiple system atrophy and vocal cord palsy,” J. Neurol. Neurosurg. Psychiatry 62: 234–8.
Herer, B., Arnulf, I., and Housset, B. (2001). “Effects of levodopa on pulmonary function in Parkinson’s disease,” Chest 119: 387–93.
Hernández-Fernández, F., Pardal-Fernández, J. M., García-Martínez, E., and Segura, T. (2011). “Respiratory myoclonus, a side effect of galantamine,” Farm Hosp. 35: 97–9.
Hill, A. N., Jankovic, J., Vuong, K. D., and Donovan, D. (2003). “Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism,” Mov. Disord. 18: 1190–2.
Ho, A. K., Bradshaw, J. L., and Iansek, R. (2008). “For better or worse: the effect of levodopa on speech in Parkinson’s disease,” Mov. Disord. 23: 574–80.
Hoffman, R., Yahr, W., and Krieger, B. (1990). “Diaphragmatic flutter resulting in failure to wean from mechanical ventilator support after coronary artery bypass surgery,” Crit. Care Med. 18: 499–501.
Hofmann, C., Penner, U., Dorow, R., Pertz, H. H., Jähnichen, S., Horowski, R., et al. (2006). “Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis,” Clin. Neuropharmacol. 29: 80–6.
Holty, J. E. and Guilleminault, C. (2010). “Surgical options for the treatment of obstructive sleep apnea,” Med. Clin. North Am. 94: 479–515.
Homma, T., Ogawa, R., Kikuchi, N., and Mizukami, K. (2007). “Respiratory chemosensitivity in dementia with Lewy bodies,” Nihon Kokyuki Gakkai Zasshi 45: 297–300.
Hou, J. G., Ondo, W., and Jankovic, J. (2001). “Intrathecal baclofen for dystonia,” Mov. Disord. 16: 1201–2.
Hovestadt, A., Bogaard, J. M., Meerwaldt, J. D., van der Meché, F. G., and Stigt, J. (1989). “Pulmonary function in Parkinson’s disease,” J. Neurol. Neurosurg. Psychiatry 52: 329–33.
Iliceto, G., Thompson, P. D., Day, B. L., Rothwell, J. C., Lees, A. J., and Marsden, C. D. (1990). “Diaphragmatic flutter, the moving umbilicus syndrome, and ‘belly dancer’s’ dyskinesia,” Mov. Disord. 5: 15–22.
Inada, T., Yagi, G., Kaijima, K., Ohnishi, K., Kamisada, M., and Rockhold, R. W. (1991). “Clinical variants of tardive dyskinesia in Japan,” Jpn. J. Psychiatry Neurol. 45: 67–71.
Inzelberg, R., Peleg, N., Nisipeanu, P., Magadle, R., Carasso, R. L., and Weiner, P. (2005). “Inspiratory muscle training and the perception of dyspnea in Parkinson’s disease,” Can. J. Neurol. Sci. 32: 213–17.
Iranzo, A., Santamaria, J., and Tolosa, E. (2000). “Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy,” Lancet Neurol. 356: 1329–30.
Iranzo, A., Muñoz, E., Santamaria, J., Vilaseca, I., Milà, M., and Tolosa, E. (2003). “REM sleep behavior disorder and vocal cord paralysis in Machado-Joseph disease,” Mov. Disord. 18: 1179–83.
Iranzo, A., Santamaria, J., Tolosa, E., Vilaseca, I., Valldeoriola, F., Marti, M. J., et al. (2004). “Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy,” Neurology 63: 930–2.
Isozaki, E., Osanai, R., Horiguchi, S., Hayashida, T., Hirose, K., and Tanabe, H. (1994). “Laryngeal electromyography with separated surface electrodes in patients with multiple system atrophy presenting with vocal cord paralysis,” J. Neurol. 241: 551–6.
Isozaki, E., Naito, A., Horiguchi, S., Kawamura, R., Hayashida, T., and Tanabe, H. (1996). “Early diagnosis and stage classification of vocal cord abductor paralysis in patients with multiple system atrophy,” J. Neurol. Neurosurg. Psychiatry 60: 399–402.
Izquierdo-Alonso, J. L., Jimenez-Jimenez, F. J., Cabrera-Valdivia, F., and Mansilla-Lesmes, M. (1994). “Airway dysfunction in patients with Parkinson’s disease,” Lung 172: 47–55.
Jackson, I. V., Volavka, J., James, B., and Reker, D. (1980). “The respiratory components of tardive dyskinesia,” Biolo. Psychiatry 15: 485–7.
Jankovic, J. (2006). “Treatment of dystonia,” Lancet Neurol. 5: 864–72.
Jankovic, J. (2009a). “Treatment of hyperkinetic movement disorders,” Lancet Neurol. 8: 844–56.
Jankovic, J. (2009b). “Disease-oriented approach to botulinum toxin use,” Toxicon. 54: 614–23.
Jankovic, J. (2010). “Camptocormia, head drop and other bent spine syndromes: heterogeneous etiology and pathogenesis of parkinsonian deformities,” Mov. Disord. 25: 527–8.
Jankovic, J. and Clarence-Smith, K. (2011). “Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders,” Expert Rev. Neurother. 11: 1509–23.
Jankovic, J. and Nour, F. (1986). “Respiratory dyskinesia in Parkinson’s disease,” Neurology 36: 303–4.
Jankovic, J. and Pardo, R. (1986). “Segmental myoclonus: clinical and pharmacologic study,” Arch. Neurol. 43: 1025–31.
Jankovic, J. and Rohaidy, H. (1987). “Motor, behavioral and pharmacologic findings in Tourette’s syndrome,” Can. J. Neurol. Sci. 14(Suppl. 3): 541–6.
Jankovic, J. and Tintner, R. (2001). “Dystonia and parkinsonism,” Parkinsonism Relat. Disord. 8: 109–21.
Jankovic, J. and Aguilar, L. G. (2008). “Current approaches to the treatment of Parkinson’s disease,” Neuropsychiatr. Dis. Treat. 4: 743–57.
Jankovic, J., Jimenez-Shahed, J., and Brown, L. W. (2009). “A randomized, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome,” Mov. Disord. 24(Suppl. 1): S497.
Jin, K., Okabe, S., Chida, K., Abe, N., Kimpara, T., Ohnuma, A., et al. (2007). “Tracheostomy can fatally exacerbate sleep-disordered breathing in multiple system atrophy,” Neurology 68: 1618–21.
Kato, B., Yamada, K., Horiuchi, M., Hirayama, T., and Hasegawa, Y. (2007). “Case of Parkinson’s disease presenting with unique dyspneic attacks caused by oromandibular dystonia and sleep apnea syndrome,” Rinsho Shinkeigaku 47: 577–80.
Kawasaki, H., Yamamoto, M., Okayasu, H., and Wakayama, Y. (1991). “A case of respiratory dyskinesia due to clebopride malate,” Rinsho Shinkeigaku 31: 878–81.
Kefalopoulou, Z., Paschali, A., Markaki, E., Vassilakos, P., Ellul, J., and Constantoyannis, C. (2009). “A double-blind study on a patient with tardive dyskinesia treated with pallidal deep brain stimulation,” Acta Neurol. Scand. 119: 269–73.
Kenney, C. and Jankovic, J. (2006). “Tetrabenazine in the treatment of hyperkinetic movement disorders,” Expert Rev. Neurotherapeutics 6: 7–17.
Kenney, C., Hunter, C., Mejia, N., and Jankovic, J. (2007). “Tetrabenazine in the treatment of Tourette syndrome,” J. Ped. Neurol. 5: 9–13.
Kenyon, G. S., Apps, M. C., and Traub, M. (1984). “Stridor and obstructive sleep apnea in Shy-Drager syndrome treated by laryngofissure and cord lateralization,” Laryngoscope 94: 1106–8.
Kerr, A. M., Armstrong, D. D., Prescott, R. J., Doyle, D., and Kearney, D. L. (1997). “Rett syndrome: analysis of deaths in the British survey,” Eur. Child Adolesc. Psychiatry 6(Suppl. 1): 71–4.
Khan, W., Naz, S., and Rana, A. Q. (2009). “Shortness of breath, a ‘wearing-off’ symptom in Parkinson’s disease,” Clin. Drug Investig. 29: 689–91.
Kim, H., Moote, W., and Mazza, J. (1997). “Tourette’s syndrome in patients referred for allergy evaluation,” Ann. Allergy Asthma Immunol. 79: 347–9.
Kim, H. J. and Jeon, B. S. (2009). “Acute respiratory failure due to vocal cord paralysis in a patient with Parkinson’s disease,” Mov. Disord. 24: 1862–3.
Kirton, C. A. and Riopelle, R. J. (2001). “Meige syndrome secondary to basal ganglia injury: a potential cause of acute respiratory distress,” Can. J. Neurol. Sci. 28: 167–73.
Klap, P., Marion, M.-H., Perrin, A., Fresnet-Elbaz, E., and Cohen, M. (1993). “Indication de la toxine botulique en laryngologie,” Rev. Laryngol. Otol. Rhinol. 114: 281–7.
Klap, P., Cohen, M., van Prooyen Keyzes, S., Perrin, A., and Ayache, D. (2003). “Laryngeal dystonia,” Rev. Neurol. 159: 916–22.
Kleiner-Fisman, G. and Lang, A. E. (2007). “Benign hereditary chorea revisited: A journey to understanding,” Mov. Disord. 22: 2297–305.
Köllensperger, M., Geser, F., Seppi, K., Stampfer-Kountchev, M., Sawires, M., Scherfler, C., et al. (2008). “Red flags for multiple system atrophy,” Mov. Disord. 23: 1093–9.
Komatsu, S., Kirino, E., Inoue, Y., and Arai, H. (2005). “Risperidone withdrawal-related respiratory dyskinesia: a case diagnosed by spirography and fibroscopy,” Clin. Neuropharmacol. 28: 90–3.
Krause, E. and Gürkov, R. (2009). “Local botulinum neurotoxin. A therapy in tardive lingual dyskinesia,” Laryngorhinootologie 88: 508–10.
Kruk, J., Sachdev, P., and Singh, S. (1995). “Neuroleptic-induced respiratory dyskinesia,” J. Neuropsychiatry Clin. Neurosci. 7: 223–9.
Kuwabara, T. (2002). “Pergolide-induced pleural effusion in a patient with juvenile parkinsonism,” Rinsho Shinkeigaku. 42: 757–60.
Kuźniar, T. J., Morgenthaler, T. I., Prakash, U. B., Pallanch, J. F., Silber, M. H., and Tippmann-Peikert, M. (2009). “Effects of continuous positive airway pressure on stridor in multiple system atrophy-sleep laryngoscopy,” J. Clin. Sleep Med. 5: 65–7.
Kwak, C., Dat Vuong, K., and Jankovic, J. (2003). “Premonitory sensory phenomenon in Tourette’s syndrome,” Mov. Disord. 18: 1530–3.
Lagueny, A., Burbaud, P., Le Masson, G., Bergouignan, F. X., Ferrer, X., and Julien, J. (1995). “Involvement of respiratory muscles in adult-onset dystonia: a clinical and electrophysiological study,” Mov. Disord. 10: 708–13.
Lam, K. S., Bodfish, J. W., and Piven, J. (2008). “Evidence for three subtypes of repetitive behavior in autism that differ in familiality and association with other symptoms,” J. Child Psychol. Psychiatry 49: 1193–200.
Larner, A. J. (2005). “Antony van Leeuwenhoek and the description of diaphragmatic flutter (respiratory myoclonus),” Mov. Disord. 20: 917–18.
Leeuwenhoek, A. (1723). “De globulorum sanguineorum magnitudine,” Philos. Trans. R. Soc. Lond. 32: 341–3.
Lew, M. F., Shindo, M., Moskowitz, C. B., Wilhelmsen, K. C., Fahn, S., and Waters, C. H. (1994). “Adductor laryngeal breathing dystonia in a patient with Lubag (x-linked dystonia-Parkinson syndrome),” Mov. Disord. 9: 318–20.
Litvan, I., Mangone, C. A., McKee, A., Verny, M., Parsa, A., Jellinger, K., et al. (1996). “Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study,” J. Neurol. Neurosurg. Psychiatry 60: 615–20.
Logemann, J. A., Gensler, G., Robbins, J., Lindblad, A. S., Brandt, D., Hind, J. A., et al. (2008). “A randomized study of three interventions for aspiration of thin liquids in patients with dementia or Parkinson’s disease,” J. Speech Lang. Hear. Res. 51: 173–83.
Louter, M., Pelleboer, R. H., van den Broek, G. B., Post, B., Pevernagie, D. A., and Overeem, S. (2011). “Nocturnal stridor in multiple system atrophy,” Ned. Tijdschr. Geneeskd. 155: A3621.
Maher, E. R. and Lees, A. J. (1986). “The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy),” Neurology 36: 1005–8.
Marion, M.-H., Klap, P., Perrin, A., and Cohen, M. (1992). “Stridor and focal laryngeal dystonia,” Lancet Neurol. 339: 457–8.
Mariotti, P., Fasano, A., Contarino, M. F., Della Marca, G., Piastra, M., Genovese, O., et al. (2007). “Management of status dystonicus: our experience and review of the literature,” Mov. Disord. 22: 963–8.
McDaid, C., Durée, K. H., Griffin, S. C., Weatherly, H. L., Stradling, J. R., Davies, R. J., et al. (2009). “A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome,” Sleep Med. Rev. 13: 427–36.
Mehanna, R. and Jankovic, J. (2010). “Respiratory problems in neurologic movement disorders,” Parkinsonism Relat. Disord. 16: 628–38.
Mehanna, R. and Jankovic, J. (2012). “Respiratory disorders associated with dystonia,” Mov. Disord. 27(14): 1816–19.
Mejia, N. and Jankovic, J. (2010). “Tardive dyskinesia and withdrawal emergent in children,” Expert Rev. Neurother. 10: 893–901.
Mendhekar, D. N. and Inamdar, A. (2010). “Withdrawal-emergent respiratory dyskinesia with risperidone treated with clozapine,” J. Neuropsychiatry Clin. Neurosci. 22: E24.
Menezes, C. and Melo, A. (2009). “Does levodopa improve swallowing dysfunction in Parkinson’s disease patients?J. Clin. Pharm. Ther. 34: 673–6.
Merlo, I. M., Occhini, A., Pacchetti, C., and Alfonsi, E. (2002). “Not paralysis, but dystonia causes stridor in multiple system atrophy,” Neurology 58: 649–52.
Mestre, T., Ferreira, J., Coelho, M. M., Rosa, M., and Sampaio, C. (2009). “Therapeutic interventions for symptomatic treatment in Huntington’s disease,” Cochrane Database Syst. Rev. (3): CD006456.
Mizukami, K., Homma, T., Aonuma, K., Kinoshita, T., Kosaka, K., and Asada, T. (2009). “Decreased ventilatory response to hypercapnia in dementia with Lewy bodies,” Ann. Neurol. 65: 614–17.
Mostile, G. and Jankovic, J. (2009). “Treatment of dysautonomia associated with Parkinson’s disease,” Parkinsonism Relat. Disord. 15(Suppl. 3): S224–32.
Muirhead, W., Jalloh, I., and Vloeberghs, M. (2010). “Status dystonicus resembling the intrathecal baclofen withdrawal syndrome: a case report and review of the literature,” J. Med. Case Reports 4: 294.
Nóbrega, A. C., Rodrigues, B., and Melo, A. (2008). “Is silent aspiration a risk factor for respiratory infection in Parkinson’s disease patients?Parkinsonism Relat. Disord. 14(8): 646–8.
Nonaka, M., Imai, T., Shintani, T., Kawamata, M., Chiba, S., and Matsumoto, H. (2006). “Non-invasive positive pressure ventilation for laryngeal contraction disorder during sleep in multiple system atrophy,” J. Neurol. Sci. 247: 53–8.
Nugent, C. A., Harris, H. W., Cohn, J., Smith, C. C., and Tyler, F. H. (1958). “Dyspnea as a symptom in Parkinson’s syndrome,” Am. Rev. Tuberc. 78: 682–91.
O’Suilleabhain, P. and Dewey, R. B. (2003). “A randomized trial of amantadine in Huntington disease,” Arch. Neurol. 60: 996–8.
Ondo, W. G., Hanna, P., and Jankovic, J. (1999). “Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol,” Am. J. Psych. 156: 1279–81.
Onodera, H., Okabe, S., Kikuchi, Y., Tsuda, T., and Itoyama, Y. (2000). “Impaired chemosensitivity and perception of dyspnea in Parkinson’s disease,” Lancet Neurol. 356: 739–40.
Onoue, H., Yukitake, M., Kurohara, K., Takasima, H., and Kuroda, Y. (2003). “A case report of Parkinson’s disease presenting with recurrent dyspneic attacks due to focal laryngeal dystonia,” Rinsho Shinkeigaku 43: 192–4.
Opal, P., Tintner, R., Jankovic, J., Leung, J., Breakfield, X. O., Friedman, J., et al. (2002). “Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic storm,” Mov. Disord. 17: 339–45.
Oyama, G., Foote, K. D., Iyer, S. S., Zeilman, P., Hwynn, N., Jacobson, C. E., et al. (2011). “Unilateral GPi-DBS as a treatment for levodopa-induced respiratory dyskinesia in Parkinson disease,” Neurologist 17: 282–5.
Panegyres, P. K., Hillman, D., and Dunne, J. W. (2007). “Laryngeal dystonia causing upper airway obstruction in progressive supranuclear palsy,” J. Clin. Neurosci. 14: 380–1.
Papapetropoulos, S., Singer, C., McCorquodale, D., Gonzalez, J., and Mash, D. C. (2005). “Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP),” Parkinsonism Relat. Disord. 11: 459–63.
Papapetropoulos, S., Papapetropoulos, N., and Singer, C. (2007). “Primary craniocervical dystonia presenting as a respiratory emergency,” Neurology 68: 388–9.
Parkinson, J. (1817). An Essay on the Shaking Palsy (London: Sherwood, Nealy and Jones).
Pasricha, P. J., Pehlivanov, N., Sugumar, A., and Jankovic, J. (2006). “Drug insight: from disturbed motility to disordered movement – a review of the clinical benefits and medicolegal risks of metoclopramide,” Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 138–48.
Protas, E. J., Stanley, R., and Jankovic, J. (1996). “Exercise and Parkinson’s disease,” Crit. Rev. Phys. Rehabil. Med. 8: 253–66.
Qureshi, A. and Hennessy, M. (2012). “Stiff person syndrome (SPS) complicated by respiratory failure: successful treatment with rituximab,” J. Neurol. 259: 180–1.
Ramirez, J., Leon, I., and Rivera, L. M. (1986). “Episodic laryngeal dyskinesia. Clinical and psychiatric characterization,” Chest 90: 716–21.
Regan, J., Walshe, M., and Tobin, W. O. (2010). “Immediate effects of thermal-tactile stimulation on timing of swallow in idiopathic Parkinson’s disease,” Dysphagia 25: 207–15.
Rice, J. E., Antic, R., and Thompson, P. D. (2002). “Disordered respiration as a levodopa-induced dyskinesia in Parkinson’s disease,” Mov. Disord. 17: 524–7.
Rich, M. W. and Radwany, S. M. (1994). “Respiratory dyskinesia. An underrecognized phenomenon,” Chest 105: 1826–32.
Rigatto, M. and de Medeiros, N. (1962). “Diaphragmatic flutter. Report of a case and review of literature,” Am. J. Med. 32: 103–9.
Rosas-Salazar, C., Gunawardena, S. W. and Spahr, J. E. (2012). “Malignant pleural mesothelioma in a child with ataxia-telangiectasia,” Pediatr. Pulmonol. [E-pub ahead of print].
Sabaté, M., González, I., Ruperez, F., and Rodríguez, M. (1996). “Obstructive and restrictive pulmonary dysfunctions in Parkinson’s disease,” J. Neurol. Sci. 138: 114–19.
Sabaté, M., Rodríguez, M., Méndez, E., Enríquez, E., and González, I. (1996). “Obstructive and restrictive pulmonary dysfunction increases disability in Parkinson’s disease,” Arch. Phys. Med. Rehabil. 77: 29–34.
Sadaoka, T., Kakitsuba, N., Fujiwara, Y., Kanai, R., and Takahashi, H. (1996). “Sleep-related breathing disorders in patients with multiple system atrophy and vocal fold palsy,” Sleep 19: 479–80.
Sakas, D. E., Panourias, I. G., Stavrinou, L. C., Boviatsis, E. J., Themistocleous, M., Stathis, P., et al. (2010). “Restoration of erect posture in idiopathic camptocormia by electrical stimulation of the globus pallidus internus,” J. Neurosurg. 113: 1246–50.
Sako, W., Goto, S., Shimazu, H., Murase, N., Matsuzaki, K., Tamura, T., et al. (2008). “Bilateral deep brain stimulation of the globus pallidus internus in tardive dystonia,” Mov. Disord. 15(23): 1929–31.
Sako, W., Nishio, M., Maruo, T., Shimazu, H., Matsuzaki, K., Tamura, T., et al. (2009). “Subthalamic nucleus deep brain stimulation for camptocormia associated with Parkinson’s disease,” Mov. Disord. 24: 1076–9.
Saleem, A. F., Sapienza, C. M., and Okun, M. S. (2005). “Respiratory muscle strength training: treatment and response duration in a patient with early idiopathic Parkinson’s disease,” NeuroRehabilitation 20: 323–33.
Salvatore, E., Di Maio, L., Filla, A., Ferrara, A. M., Rinaldi, C., Saccà, F., et al. (2010). “Benign hereditary chorea: clinical and neuroimaging features in an Italian family,” Mov. Disord. 25: 1491–6.
Sant’Ambrogio, F. B., Mathew, O. P., Clark, W. D., and Sant’Ambrogio, G. (1985). “Laryngeal influences on breathing pattern and posterior cricoarytenoid muscle activity,” J. Appl. Physiol. 58: 1298–304.
Santiago-Palma, J., Hord, E. D., Vallejo, R., Trella, J., and Ahmed, S. U. (2004). “Respiratory distress after intrathecal baclofen withdrawal,” Anesth. Analg. 99: 227–9.
Sapienza, C., Troche, M., Pitts, T., and Davenport, P. (2011). “Respiratory strength training: concept and intervention outcomes,” Semin. Speech Lang. 32: 21–30.
Sathyaprabha, T. N., Kapavarapu, P. K., Pall, P. K., Thennarasu, K., and Raju, T. R. (2005). “Pulmonary functions in Parkinson’s disease,” Indian J. Chest Dis. Allied Sci. 47: 251–7.
Schwab, R. D., England, A. C., and Peterson, E. (1959). “Akinesia in Parkinson’s disease,” Neurology 9: 65–72.
Sekita, Y., Shiba, K., Nakazawa, K., Numasawa, T., and Isono, S. (2004). “Inspiratory activation of the vocal cord adductor. Part II: Animal study in the cat,” Laryngoscope 114: 376–80.
Serebrovskaya, T., Karacan, I., Mankovskaya, I., Bernardi, L., Passino, C., and Appenzeller, O. (1998). “Hypoxic ventilatory response and gas exchange in patients with Parkinson’s disease,” Respiration 65: 28–33.
Setter, S. M., Neumiller, J. J., Dobbins, E. K., Wood, L., Clark, J., DuVall, C. A., et al. (2009). “Treatment of chorea associated with Huntington’s disease: focus on tetrabenazine,” Consult Pharm. 24: 524–37.
Shiba, K., Isono, S., and Nakazawa, K. (2007). “Paradoxical vocal cord motion: a review focused on multiple system atrophy,” Auris Nasus Larynx 34: 443–52.
Shiba, K., Isono, S., Sekita, Y., and Tanaka, A. (2004). “Inspiratory activation of the vocal cord adductor. Part I: Human study in patients with restricted abduction of the vocal cords,” Laryngoscope 114: 372–5.
Shill, H. and Stacy, M. (2002). “Respiratory complications of Parkinson’s disease,” Semin. Respir. Crit. Care Med. 23: 261–5.
Silay, Y. and Jankovic, J. (2005). “Emerging drugs in Tourette syndrome,” Expert Opin. Emerg. Drugs 10: 365–80.
Silber, M. H. and Levine, S. (2000). “Stridor and death in multiple system atrophy,” Mov. Disord. 15: 699–704.
Smith, S. A., Waggoner, A. D., de las Fuentes, L., and Davila-Roman, V. G. (2009). “Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiography,” J. Am. Soc. Echocardiogr. 22: 883–9.
Solomon, N. P. and Hixon, T. J. (1993). “Speech breathing in Parkinson’s disease,” J. Speech Hear. Res. 36: 294–310.
South, A. R., Somers, S. M., and Jog, M. S. (2010). “Gum chewing improves swallow frequency and latency in Parkinson patients: a preliminary study,” Neurology 74: 1198–202.
Stanley, R. K., Protas, E. J., and Jankovic, J. (1999). “Exercise responses in those having Parkinson’s disease and healthy normals,” Med. Sci. Sports Exerc. 31: 761–6.
Steffen, A., Hagenah, J., Graefe, H., Mahlerwein, M., and Wollenberg, B. (2008). “Obstructive sleep apnea in patients with Parkinson’s disease – report of two cases and review,” Laryngorhinootologie 87: 107–11.
Sun, B., Chen, S., Zhan, S., Le, W., and Krahl, S. E. (2007). “Subthalamic nucleus stimulation for primary dystonia and tardive dystonia,” Acta Neurochir. Suppl. 97(Pt. 2): 207–14.
Suzuki, M., Saigusa, H., Shibasaki, K., and Kodera, K. (2010). “Multiple system atrophy manifesting as complex sleep-disordered breathing,” Auris Nasus Larynx 37: 110–13.
Sverd, J. and Montero, G. (1993). “Is Tourette syndrome a cause of sudden infant death syndrome and childhood obstructive sleep apnea?Am. J. Med. Genet. 46: 494–6.
Tan, E. K. and Jankovic, J. (1999). “Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up,” Neurology 53: 2102–7.
Tan, H., Büyükavci, M., and Arik, A. (2004). “Tourette’s syndrome manifests as chronic persistent cough,” Yonsei Med. J. 45: 145–9.
Tanner, K., Roy, N., Merrill, R. M., Sauder, C., Houtz, D. R., and Smith, M. E. (2011). “Spasmodic dysphonia: onset, course, socioemotional effects, and treatment response,” Ann. Otol. Rhinol. Laryngol. 120: 465–73.
Tarsy, D. and Simon, D. K. (2006). “Dystonia,” NEJM 355: 818–27.
Tintner, R., Manian, P., Gauthier, P., and Jankovic, J. (2005). “Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson disease,” Arch. Neurol. 62: 1290–5.
Troche, M. S., Huebner, I., Rosenbek, J. C., Okun, M. S., and Sapienza, C. M. (2011). “Respiratory-swallowing coordination and swallowing safety in patients with Parkinson’s disease,” Dysphagia 26: 218–24.
Troche, M. S., Okun, M. S., Rosenbek, J. C., Musson, N., Fernandez, H. H., Rodriguez, R., et al. (2010). “Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial,” Neurology 75: 1912–19.
Tsai, C. S., Lee, Y., Chang, Y. Y., and Lin, P. Y. (2008). “Ziprasidone-induced tardive laryngeal dystonia: a case report,” Gen. Hosp. Psychiatry 30: 277–9.
Tschopp, L., Salazar, Z., and Micheli, F. (2009). “Botulinum toxin in painful tardive dyskinesia,” Clin. Neuropharmacol. 32: 165–6.
Tsuda, T., Onodera, H., Okabe, S., Kikuchi, Y., and Itoyama, Y. (2002). “Impaired chemosensitivity to hypoxia is a marker of multiple system atrophy,” Ann. Neurol. 52: 367–71.
Umeno, H., Ueda, Y., Mori, K., Chijiwa, K., Nakashima, T., and Kotby, N. (2000). “Management of impaired vocal fold movement during sleep in a patient with Shy-Drager syndrome,” Am. J. Otolaryngol. 21: 344–78.
van Harten, P. N. and Tenback, D. E. (2011). “Tardive dyskinesia: clinical presentation and treatment,” Int. Rev. Neurobiol. 98: 187–210.
Vazquez, A., Jimenez-Jimenez, F. J., Garcia-Ruiz, P., and Garcia-Urra, D. (1993). “‘Panic attacks’ in Parkinson’s disease: a long-term complication of levodopa therapy,” Acta Neurol. Scand. 87: 14–18.
Verhagen, M. M., Abdo, W. F., Willemsen, M. A., Hogervorst, F. B., Smeets, D. F., Hiel, J. A., et al. (2009). “Clinical spectrum of ataxia-telangiectasia in adulthood,” Neurology 73: 430–7.
Vetrugno, R., Provini, F., Cortelli, P., Plazzi, G., Lotti, E. M., Pierangeli, G., et al. (2004). “Sleep disorders in multiple system atrophy: a correlative video-polysomnographic study,” Sleep Med. 5: 21–30.
Vetrugno, R., Liguori, R., Cortelli, P., Plazzi, G., Vicini, C., Campanini, A., et al. (2007). “Sleep-related stridor due to dystonic vocal cord motion and neurogenic tachypnea/tachycardia in multiple system atrophy,” Mov. Disord. 22: 673–8.
Vincken, W. G., Gauthier, S. G., Dollfuss, R. E., Hanson, R. E., Darauay, C. M., and Cosio, M. G. (1984). “Involvement of upper-airway muscles in extrapyramidal disorders: a cause of airflow limitation,” N. Engl. J. Med. 311: 438–42.
Waller, E. A. and Kaplan, J. (2006). “Pergolide-associated valvular heart disease,” Compr. Ther. 32: 94–101.
Weisman, D. and McKeith, I. (2007). “Dementia with Lewy bodies,” Semin. Neurol. 27: 42–7.
Werner, W. J., Goetz, C. C., Nausieda, P. A., and Klawans, H. L. (1978). “Respiratory dyskinesia: extrapyramidal dysfunction and dyspnea,” Ann. Intern. Med. 88: 327–31.
Williams, D. R. and Lees, A. J. (2009). “Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges,” Lancet Neurol. 8: 270–9.
Wood, H. (2010). “Parkinson disease: deep brain stimulation can alter speech-related respiratory and laryngeal control in Parkinson disease,” Nat. Rev. Neurol. 6: 468.
Worley, G., Witsell, D. L., and Hulka, G. F. (2003). “Laryngeal dystonia causing inspiratory stridor in children with cerebral palsy,” Laryngoscope 113: 2192–5.
Wujtewicz, M. A., Chwojnicki, K., Owczuk, R., and Wujtewicz, M. (2012). “Laryngeal dystonia in the course of multiple system atrophy: a cause of postoperative respiratory insufficiency,” Neurol. Sci. 33: 681–3.
Yamaguchi, M., Arai, K., Asahina, M., and Hattori, T. (2003). “Laryngeal stridor in multiple system atrophy,” Eur. Neurol. 49: 154–9.
Yokoji, I., Nakamura, S., and Ikeda, T. (1997). “A case of progressive supranuclear palsy associated with bilateral vocal cord abductor paralysis,” Rinsho Shinkeigaku 37: 523–5.
Yokoyama, M., Honda, M., Okoshi, Y., Masuyama, T., Iwasaki, Y., and Arima, M. (2011). “Efficacy of botulinum toxin type A against cervical dystonia and muscular hypertonia in persons with severe motor and intellectual disabilities with respiratory problems and/or dysphagia,” No To Hattatsu 43: 273–6.
Yoshimura, M. (1997). “Diffuse Lewy body disease,” Rinsho Shinkeigaku 37: 1134–6.
Zadikoff, C., Lang, A. E., and Klein, C. (2006). “The ‘essentials’ of essential palatal tremor: a reappraisal of the nosology,” Brain 129: 832–40.
Zwirner, P., Dressler, D., and Kruse, E. (1997). “Spasmodic laryngeal dyspnea: a rare manifestation of laryngeal dystonia,” Eur. Arch. Otorhinolaryngol. 254: 242–5.